Information regarding Cystic Fibrosis, the types of research being performed to finds its cure.  Learn more about gene therapy, and treatments for Cystic Fibrosis as well as volunteering opportunities.
The Center has many research laboratories dedicated to finding a cure for Cystic Fibrosis.  Meet the different lab directors, their lab members and the laboratories particular focus.
A complete list of publications from the Centers lab directors that are related to Cystic Fibrosis.
Apply for open positions at the Cystic Fibrosis Research Development Center.
Visit other websites of organizations and associations affiliated with Cystic Fibrosis.
Letter from the Director addressing the Centers continued plan for the future.






















Beth L. Laube



Beth L. Laube

Associate Professor
The Johns Hopkins University School of Medicine
Department of Pediatrics
Division of Pediatric Pulmonary
Baltimore, MD
600 North Wolfe Street
Baltimore, Maryland 21287-2533 


Beth Laube


B.A., Lake Forest College
Ph.D., The Johns Hopkins Bloomberg School of Public Health

  Research Interests

Beth L. Laube holds a Ph.D. from the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland and is currently an Associate Professor of Pediatrics at the Johns Hopkins School of Medicine. Dr. Laube is President of the International Society for Aerosols in Medicine (ISAM) and is a member of the American Thoracic Society. She serves on the Editorial Board of the Journal of Aerosol Medicine, on the advisory committee to the World Health Organization Product Development Group for the Aerosolized Measles Vaccine Project and on the National Academy of Science’s Committee on Animal Models for Testing Interventions Against Aerosolized Bioterrorism Agents. Dr. Laube is a frequent advisor to pre-doctoral candidates and post-doctoral fellows at the Johns Hopkins University and at the University of Maryland and has published over 40 peer-reviewed articles.

Dr. Laube’s research involves in vivo quantification of the deposition and removal of particles in healthy and diseased lungs and noses, using radiolabeled aerosols and scintigraphic imaging assessments. Computer analyses of the scintigraphic images can be combined with functional measurements of changes in airway responsiveness to provide improved methods for assessing the efficacy of a variety of inhaled medications that are administered to the lung or nose for topical administration, or with the systemic circulation as the target. This approach is very useful in the development of aerosol therapies for treating asthma, cystic fibrosis, lung transplant patients and diabetes and for answering basic physiologic questions about mucociliary clearance, a major lung defense mechanism.




1992:  Faculty Development Award: Bloomberg School of Public Health
1994:  3M Corporate Science Prize


Complete List

Lab Members
Complete List

615 N. Wolfe Street, Baltimore, MD 21205